Examples of BPCI Act in a sentence
However, the BPCI Act does provide a mechanism for a competitor to challenge the validity of an innovator’s patents as early as four years after initial marketing approval of the innovator biologic.
Specifically, the Biologics Price Competition and Innovation Act of 2009, or the BPCI Act, amended the Public Health Service Act to provide an abbreviated licensure pathway for biological products, or 351(k) application, shown to be biosimilar to, or interchangeable with, an FDA-licensed biological reference product.
FDA believes that guidance for industry that provides answers to commonly asked questions regarding FDA’s interpretation of the BPCI Act will enhance transparency and facilitate the development and approval of biosimilar and interchangeable products.
The objectives of the BPCI Act are conceptually similar to those of the Drug Price Competition and Patent Term Restoration Act of 1984 (Pub.
BACKGROUND The BPCI Act was enacted as part of the Affordable Care Act on March 23, 2010.
BACKGROUND The BPCI Act The BPCI Act was enacted as part of the ACA on March 23, 2010.
The objectives of the BPCI Act are conceptually similar to those of the Drug Price Competition and Patent Term Restoration Act of 1984 (Public Law 98-417) (commonly referred to as the “Hatch-Waxman Amendments”), which established abbreviated pathways for the approval of drug products under section 505(b)(2) and 505(j) of the FD&C Act.
Q.II.1. [This question and answer have been withdrawn and moved to FDA’s draft guidance for industry, New and Revised Draft Q&As on Biosimilar Development and the BPCI Act (Revision 2).] Q.
FDA is also issuing a draft guidance document entitled New and Revised Draft Q&As on Biosimilar Development and the BPCI Act (Revision 2).
Specifically, courts have now held that biosimilar applicants are not required to engage in the BPCI Act litigation scheme.